Healthcare

10 Jan 2018  |  Asia Pacific  |  Mega Trends

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Ko...

This Industry Docket provides a brief overview of the healthcare opportunity landscape in Bahrain, its position among GCC countries, its health indicators and availability of healthcare facilities, changing scenarios of payer and providers, past and future trends in inpatients and outpatients. Infrastructure and care division across the private and...

The South Korean endoscopy devices market is growing under relatively lower reimbursement rates and budget constraints that are forcing hospitals to provide greater importance to pricing of equipment and changing utilization patterns. In many South Korean hospitals, consolidated purchasing of endoscopy and laparoscopy equipment slows down procureme...

Nigeria has the largest consumer base in Sub-Saharan region. A larger part of the population living in urban areas is a favorable indicator for market entry. Robust growth of around 7% for the past decade is threatened by macroeconomic challenges, particularly exchange-rate volatility and falling global oil prices that impact public-sector spending...

Frost & Sullivan defines digital health to include telehealth and healthcare IT. Telehealth covers video telemedicine, remote patient monitoring (RPM), and mobile health (mHealth) and healthcare IT (in the APAC context) refers to the software solutions deployed across hospitals in the region. It is difficult to generalize or summarize the digital h...

In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the African healthcare industry in 2017. The markets covered include pharmaceuticals and biotechnology, in-vitro diagnostics, medical devices, medical imaging and healthcare IT. The analysis captures the impact of trends that are expected ...

This market insight aims to profile select medical device companies in Asia-Pacific for 2016. Research Scope: • The aim of this insight is to analyze and profile APAC medical device manufacturers, based on certain parameters. • It covers wound management, cardiovascular, orthopedic implants, infection control, and infusion...

This industry docket provides an overview of the evolution of the healthcare industry in Dubai, key stakeholders, government licenses and permits required to set up operations in Mainland Dubai, and key investments. Substantial healthcare spending and increased access to healthcare have helped the UAE to improve its ranking in the World Healthcare...

This industry docket assess Nepal's healthcare market and highlights investment opportunities therein. The country lacks centers of excellence in tertiary care leading to outflow of patients seeking the same. Nepal is currently seeing increasing investment by private and corporate hospital sectors in speciality services like Cardiac Sciences, Neu...